Raptor Pharmaceutical Corp 4
4 · Raptor Pharmaceutical Corp · Filed Jul 9, 2014
Insider Transaction Report
Form 4
Keltner Llew
Director
Transactions
- Exercise/Conversion
Common Stock
2014-07-07$2.02/sh+9,490$19,170→ 9,490 total - Exercise/Conversion
Stock options (right to buy)
2014-07-07−9,490→ 2,488 totalExercise: $2.02Exp: 2020-03-09→ Common Stock (9,490 underlying) - Exercise/Conversion
Stock options (right to buy)
2014-07-07−510→ 29,490 totalExercise: $2.97Exp: 2020-10-12→ Common Stock (510 underlying) - Exercise/Conversion
Common Stock
2014-07-07$2.97/sh+510$1,515→ 10,000 total - Sale
Common Stock
2014-07-07$11.21/sh−10,000$112,129→ 0 total
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 14, 2013.
- [F2]Fully vested and exercisable.
- [F3]Stock options vest 6/48ths on February 28, 2011 and 1/48th per month thereafter.
- [F4]This transaction was executed in multiple trades at prices ranging from $10.89 to $11.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.